FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377014300> ?p ?o ?g. }

• W4377014300 abstract "Multiple myeloma (MM) is an incurable hematological cancer. It is preceded by monoclonal gammopathy of uncertain significance (MGUS), an asymptomatic phase. It has been demonstrated that early detection increases the 5-year survival rate. However, blood-based biomarkers that enable early disease detection are lacking. Metabolomic and lipoprotein subfraction variable profiling is gaining traction to expand our understanding of disease states and, more specifically, for identifying diagnostic markers in patients with hematological cancers. This study aims to enhance our understanding of multiple myeloma (MM) and identify candidate metabolites, allowing for more effective preventative treatment. Serum was collected from 25 healthy controls, 20 patients with MGUS, and 30 patients with MM. 1H-NMR (nuclear magnetic resonance) spectroscopy was utilized to evaluate serum samples. The metabolite concentrations were examined using multivariate, univariate, and pathway analysis. Metabolic profiles of the MGUS patients revealed lower levels of alanine (F.C. = 0.8, p = 0.002), lysine (FC = 0.8, p &amp;lt; 0.001), leucine (FC=0.7, p &amp;lt; 0.001) but higher levels of formic acid (FC=1.6, p ≤ 0.001) when compared to controls. However, metabolic profiling of MM patients compared to controls exhibited decreased levels of total Apolipoprotein-A1 (FC =0.6, p&amp;lt;0.001), HDL-4 Apolipoprotein-A1 (FC = 0.5, p ≤ 0.001), HDL-4 Apolipoprotein-A2 (FC = 0.6, p &amp;lt; 0.001), HDL Free Cholesterol (FC = 0.7, p &amp;lt; 0.001), HDL-3 Cholesterol (FC = 0.5, p ≤ 0.001) and HDL-4 Cholesterol (FC = 0.5, p ≤ 0.001). Lastly, metabolic comparison between MGUS to MM patients primarily indicated alterations in lipoproteins levels: Total Cholesterol (FC = 0.6, p ≤ 0.001), HDL Cholesterol (FC = 0.7, p ≤ 0.001), HDL Free Cholesterol (FC = 0.4, p ≤ 0.001), Total Apolipoprotein-A1 (FC = 0.7, p ≤ 0.001), HDL Apolipoprotein-A1 (FC = 0.7, p ≤ 0.001), HDL-4 Apolipoprotein-A1 (FC = 0.6, p ≤ 0.001) and HDL-4 Phospholipids (FC = 0.6, p ≤ 0.001). This study provides novel insights into the serum metabolic and lipoprotein subfraction changes in patients as they progress from a healthy state to MGUS to MM, which may allow for earlier clinical detection and treatment." @default.
• W4377014300 created "2023-05-19" @default.
• W4377014300 creator A5050363054 @default.
• W4377014300 creator A5056478743 @default.
• W4377014300 creator A5075147644 @default.
• W4377014300 creator A5076976504 @default.
• W4377014300 creator A5081201704 @default.
• W4377014300 creator A5091971501 @default.
• W4377014300 date "2023-05-18" @default.
• W4377014300 modified "2023-09-30" @default.
• W4377014300 title "Serum NMR-Based Metabolomics Profiling Identifies Lipoprotein Subfraction Variables and Amino Acid Reshuffling in Myeloma Development and Progression" @default.
• W4377014300 doi "https://doi.org/10.20944/preprints202305.1339.v1" @default.
• W4377014300 hasPublicationYear "2023" @default.
• W4377014300 type Work @default.
• W4377014300 citedByCount "0" @default.
• W4377014300 crossrefType "posted-content" @default.
• W4377014300 hasAuthorship W4377014300A5050363054 @default.
• W4377014300 hasAuthorship W4377014300A5056478743 @default.
• W4377014300 hasAuthorship W4377014300A5075147644 @default.
• W4377014300 hasAuthorship W4377014300A5076976504 @default.
• W4377014300 hasAuthorship W4377014300A5081201704 @default.
• W4377014300 hasAuthorship W4377014300A5091971501 @default.
• W4377014300 hasBestOaLocation W43770143001 @default.
• W4377014300 hasConcept C126322002 @default.
• W4377014300 hasConcept C134018914 @default.
• W4377014300 hasConcept C185592680 @default.
• W4377014300 hasConcept C21565614 @default.
• W4377014300 hasConcept C2776364478 @default.
• W4377014300 hasConcept C2777477808 @default.
• W4377014300 hasConcept C2778163477 @default.
• W4377014300 hasConcept C2779856020 @default.
• W4377014300 hasConcept C2780072125 @default.
• W4377014300 hasConcept C515207424 @default.
• W4377014300 hasConcept C55493867 @default.
• W4377014300 hasConcept C60644358 @default.
• W4377014300 hasConcept C71924100 @default.
• W4377014300 hasConcept C86803240 @default.
• W4377014300 hasConceptScore W4377014300C126322002 @default.
• W4377014300 hasConceptScore W4377014300C134018914 @default.
• W4377014300 hasConceptScore W4377014300C185592680 @default.
• W4377014300 hasConceptScore W4377014300C21565614 @default.
• W4377014300 hasConceptScore W4377014300C2776364478 @default.
• W4377014300 hasConceptScore W4377014300C2777477808 @default.
• W4377014300 hasConceptScore W4377014300C2778163477 @default.
• W4377014300 hasConceptScore W4377014300C2779856020 @default.
• W4377014300 hasConceptScore W4377014300C2780072125 @default.
• W4377014300 hasConceptScore W4377014300C515207424 @default.
• W4377014300 hasConceptScore W4377014300C55493867 @default.
• W4377014300 hasConceptScore W4377014300C60644358 @default.
• W4377014300 hasConceptScore W4377014300C71924100 @default.
• W4377014300 hasConceptScore W4377014300C86803240 @default.
• W4377014300 hasLocation W43770143001 @default.
• W4377014300 hasOpenAccess W4377014300 @default.
• W4377014300 hasPrimaryLocation W43770143001 @default.
• W4377014300 hasRelatedWork W1976602105 @default.
• W4377014300 hasRelatedWork W2028375480 @default.
• W4377014300 hasRelatedWork W2035331946 @default.
• W4377014300 hasRelatedWork W2049007839 @default.
• W4377014300 hasRelatedWork W2118738696 @default.
• W4377014300 hasRelatedWork W2147702047 @default.
• W4377014300 hasRelatedWork W2157155183 @default.
• W4377014300 hasRelatedWork W2165426876 @default.
• W4377014300 hasRelatedWork W2748952813 @default.
• W4377014300 hasRelatedWork W4244653511 @default.
• W4377014300 isParatext "false" @default.
• W4377014300 isRetracted "false" @default.
• W4377014300 workType "article" @default.